TABLE 4. Incidence of CIN: Subgroups of Patients Without and With Diabetes Mellitus
| Subgroups and Postdose | Iopamidol-370 Group | Iodixanol-320 Group | Absolute Difference (95% CI) | P* | ||
|---|---|---|---|---|---|---|
| N | n (%) | N | n (%) | |||
| *Fisher exact test. | ||||||
| Patients without diabetes mellitus | ||||||
| Increase of >0.5 mg/dL in SCr | 126 | 5 (4.0) | 118 | 2 (1.7) | 2.3 (−1.9 to 6.4) | 0.45 |
| Increase of >25% in SCr | 126 | 12 (9.5) | 118 | 12 (10.2) | −0.7 (−8.1 to 6.8) | 1.00 |
| Decrease of >25% in eGFR | 126 | 7 (5.6) | 118 | 9 (7.6) | −2.0 (−8.3 to 4.2) | 0.61 |
| Patients with diabetes mellitus | ||||||
| Increase of >0.5 mg/dL in SCr | 78 | 4 (5.1) | 92 | 12 (13.0) | −7.9 (−16.4 to 0.5) | 0.11 |
| Increase of >25% in SCr | 78 | 8 (10.3) | 92 | 14 (15.2) | −4.9 (−14.9 to 5.0) | 0.37 |
| Decrease of >25% in eGFR | 78 | 5 (6.4) | 92 | 12 (13.0) | −6.6 (−15.4 to 2.1) | 0.20 |